| Chemotaxis in cancer ET Roussos, JS Condeelis, A Patsialou Nature Reviews Cancer 11 (8), 573-587, 2011 | 1171 | 2011 |
| The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents MH Ma, HH Yang, K Parker, S Manyak, JM Friedman, C Altamirano, Z Wu, ... Clinical Cancer Research 9 (3), 1136-1144, 2003 | 574 | 2003 |
| A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis U Philippar, ET Roussos, M Oser, H Yamaguchi, HD Kim, S Giampieri, ... Developmental cell 15 (6), 813-828, 2008 | 337 | 2008 |
| N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors B Gligorijevic, J Wyckoff, H Yamaguchi, Y Wang, ET Roussos, ... Journal of cell science 125 (3), 724-734, 2012 | 331 | 2012 |
| Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer ET Roussos, M Balsamo, SK Alford, JB Wyckoff, B Gligorijevic, Y Wang, ... Journal of cell science 124 (13), 2120-2131, 2011 | 225 | 2011 |
| Entinostat converts immune-resistant breast and pancreatic cancers into checkpoint-responsive tumors by reprogramming tumor-infiltrating MDSCs BJ Christmas, CI Rafie, AC Hopkins, BA Scott, HS Ma, KA Cruz, ... Cancer immunology research 6 (12), 1561-1577, 2018 | 191 | 2018 |
| Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging D Entenberg, J Wyckoff, B Gligorijevic, ET Roussos, VV Verkhusha, ... Nature protocols 6 (10), 1500-1520, 2011 | 143 | 2011 |
| A CD40 agonist and PD-1 antagonist antibody reprogram the microenvironment of nonimmunogenic tumors to allow T-cell–mediated anticancer activity HS Ma, B Poudel, ER Torres, JW Sidhom, TM Robinson, B Christmas, ... Cancer immunology research 7 (3), 428-442, 2019 | 115 | 2019 |
| AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment ET Roussos, Z Keckesova, JD Haley, DM Epstein, RA Weinberg, ... Cancer research 70 (19), 7360-7364, 2010 | 97 | 2010 |
| Mena invasive (MenaINV) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM ET Roussos, S Goswami, M Balsamo, Y Wang, R Stobezki, E Adler, ... Clinical & experimental metastasis 28, 515-527, 2011 | 96 | 2011 |
| Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors ET Roussos, Y Wang, JB Wyckoff, RS Sellers, W Wang, J Li, JW Pollard, ... Breast Cancer Research 12, 1-16, 2010 | 94 | 2010 |
| Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase H Pang, R Flinn, A Patsialou, J Wyckoff, ET Roussos, H Wu, M Pozzuto, ... Cancer research 69 (23), 8868-8876, 2009 | 92 | 2009 |
| Clocking cancer: The circadian clock as a target in cancer therapy F Battaglin, P Chan, Y Pan, S Soni, M Qu, ER Spiller, S Castanon, ... Oncogene 40 (18), 3187-3200, 2021 | 75 | 2021 |
| Management of breast cancer during the COVID-19 pandemic: a stage-and subtype-specific approach JY Sheng, CA Santa-Maria, N Mangini, H Norman, R Couzi, R Nunes, ... JCO oncology practice 16 (10), 665-674, 2020 | 65 | 2020 |
| Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma KM Parker, MH Ma, S Manyak, CV Altamirano, YM Tang, M Frantzen, ... Cancer genetics and cytogenetics 137 (1), 43-48, 2002 | 60 | 2002 |
| Evaluating the impact of age on immune checkpoint therapy biomarkers R Erbe, Z Wang, S Wu, J Xiu, N Zaidi, J La, D Tuck, N Fillmore, NA Giraldo, ... Cell reports 36 (8), 2021 | 55 | 2021 |
| Conducting a virtual clinical trial in HER2-negative breast cancer using a quantitative systems pharmacology model with an epigenetic modulator and immune checkpoint inhibitors H Wang, RJ Sové, M Jafarnejad, S Rahmeh, EM Jaffee, V Stearns, ... Frontiers in Bioengineering and Biotechnology 8, 141, 2020 | 51 | 2020 |
| Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains HZ Mao, ET Roussos, M Péterfy Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (4), 440-446, 2006 | 45 | 2006 |
| Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment DN Sidiropoulos, CI Rafie, JK Jang, S Castanon, AG Baugh, E Gonzalez, ... Cancer immunology research 10 (5), 656-669, 2022 | 41 | 2022 |
| Differential variation analysis enables detection of tumor heterogeneity using single-cell RNA-sequencing data EF Davis-Marcisak, TD Sherman, P Orugunta, GL Stein-O'Brien, ... Cancer research 79 (19), 5102-5112, 2019 | 39 | 2019 |
Sumanta GoswamiYeshiva UniversityVerificeret mail på einstein.yu.edu
